Clinical Study of GKT in Diabetes Related Dementia
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
In 2013, Fukasawa et al. proposed a new clinical dementia subgroup based on brain imaging,
called "diabetes related dementia (DrD)". DrD, unlike Alzheimer's disease and vascular
dementia, is considered a "controllable" or "modifiable" form of dementia. However, there is
currently a lack of corresponding treatment measures. Ginkgo biloba ketone ester tablets are
extracts of Ginkgo biloba leaves. Previous studies have shown that they can increase cerebral
blood flow, reduce cerebrovascular resistance, improve cerebral circulation, and are
beneficial for the treatment of cognitive impairment. This project intends to explore the
role of ginkgo ketoester tablets in diabetes related dementia through a multicenter
randomized double-blind controlled clinical study.